XML 20 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Income - USD ($)
$ in Thousands
 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]      
Revenue $ 4,887,550 $ 4,576,697 $ 4,288,640
Operating expenses:      
Cost of revenue 3,159,941 2,957,547 2,810,967
Research and development 374,855 354,706 312,941
Selling, general and administrative 570,707 528,572 487,255
Amortization of purchased intangible assets and other 57,156 71,075 78,784
Restructuring charges 70,901 0 0
Total operating expenses 4,233,560 3,911,900 3,689,947
Operating income 653,990 664,797 598,693
Interest and other expense, net (17,629) (26,391) (10,797)
Gain from sale of a business 0 10,000 226,410
Income before income taxes 636,361 648,406 814,306
Income taxes 93,399 98,905 125,932
Net income 542,962 549,501 [1] 688,374 [1]
Net income attributable to noncontrolling interests 2,253 0 0
Net income attributable to Amdocs Limited $ 540,709 $ 549,501 $ 688,374
Basic earnings per share attributable to Amdocs Limited $ 4.52 $ 4.47 $ 5.36
Diluted earnings per share attributable to Amdocs Limited $ 4.49 $ 4.44 $ 5.32
[1] In fiscal years 2022 and 2021, all of the Company’s net income is attributable to Amdocs Limited as the net income attributable to the Non-controlling interests is negligible. Starting fiscal year 2023, the Company distributes earnings to the noncontrolling interests, for further details please refer to Note 2.